论文部分内容阅读
目的:探讨PDCA循环用于临床检验质量控制的效果。方法:对2011年6月至2013年6月我院检验科未将PDCA循环用于临床检验质量控制的检验样本设为对照组,同期对2012年3月至2014年3月我院检验科将PDCA循环用于临床检验质量控制后的检验样本设为观察组,对两组检验样本中的健康体检、门诊、住院患者的检验合格率进行对比分析,研究和分析PDCA循环用于临床检验质量控制的效果。结果:通过对两组结果的对比分析,可知观察组将PDCA循环用于临床检验质量控制的检验样本的不合格例数较少,显著少于对照组,健康体检、门诊及住院标本的不合格率依次为0.22%、0.25%、0.28%;对照组未将PDCA循环用于临床检验质量控制,健康体检、门诊及住院标本的不合格率依次为1.01%、1.08%、1.46%。两组结果相比,观察组不合格率显著低于对照组,具有显著差异性,具有统计学意义(P<0.05)。结论:将PDCA循环应用于临床检验质量控制,有利于临床检验程序的规范化,促进检验样本合格率的提高,增加临床检验质量控制的有效性。
Objective: To investigate the effect of PDCA cycle on quality control of clinical tests. Methods: From June 2011 to June 2013, our laboratory did not use the PDCA cycle for quality control of clinical tests as the control group. In the same period, from March 2012 to March 2014, PDCA cycle for the clinical examination of quality control after the test sample was set as the observation group, the two groups of test samples in the health examination, outpatient, inpatient qualified test pass rate comparison study and analysis of PDCA cycle for clinical test quality control Effect. Results: Through the comparative analysis of the two groups of results, it can be seen that the observation group used the PDCA cycle less than the number of unqualified cases of the quality control test samples in the observation group, significantly less than the unqualified ones in the control group, the physical examination, outpatient and inpatient samples The rates of success were 0.22%, 0.25% and 0.28%, respectively. The control group did not use PDCA cycle for quality control of clinical examination. The unqualified rates of physical examinations, outpatients and inpatients were 1.01%, 1.08% and 1.46%, respectively. Compared with the two groups, the failure rate of the observation group was significantly lower than that of the control group, with significant difference (P <0.05). Conclusion: The application of PDCA cycle in quality control of clinical tests is conducive to the standardization of clinical testing procedures, to promote the passing rate of test samples and to increase the effectiveness of clinical test quality control.